TrialTrials2014

A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study.

Joanna D Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.